The first (N═N) 2– complex of a rare-earth metal with an end-on dinitrogen bridge, {K(crypt)} 2 {[(R 2 N) 3 Sc] 2 [μ-η 1:η 1 -N 2 ]} (crypt = 2.2.2-cryptand, R = SiMe 3 ), has been isolated from the reduction of Sc(NR 2 ) 3 under dinitrogen at −35 °C and characterized by X-ray crystallography. The structure differs from the characteristic side-on structures previously observed for over 40 crystallographically characterized rare-earth metal (N═N) 2– complexes of formula [A 2 Ln(THF) x ] 2 [μ-η 2:η 2 -N 2 ] (Ln = Sc, Y, and lanthanides; x = 0, 1; A = anionic ligand such as amide, cyclopentadienide, and aryloxide). The 1.221(3) Å N—N distance and the 1644 cm –1 Raman stretch are consistent with the presence of an (N═N) 2– bridge. The observed paramagnetism of the complex by Evans method measurements is consistent with DFT calculations that suggest a triplet ( 3 A 2 ) ground state in D 3 symmetry involving two degenerate Sc—N 2 —Sc bonding orbitals. Upon brief exposure of the orange Sc 3+ bridging dinitrogen complex to UV-light, photolysis to form the monomeric Sc 2+ complex, [K(crypt)][Sc(NR 2 ) 3 ], was observed. Conversion of the Sc 2+ complex to the Sc 3+ dinitrogen complex was not observed with this crypt system, but it did occur with the 18-crown-6 (crown) analog which formed {K(crown)} 2 {[(R 2 N) 3 Sc] 2 [μ-η 1:η 1 -N 2 ]}. This suggests the importance of the alkali metal chelating agent in the reversibility of dinitrogen binding in this scandium system.
No takes yet. Share an insight, caveat, or question.
Woen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: